Search filters
Filters
Clear All

Phase

  • 182
  • 151
  • 2
  • 188
  • 147
  • 17
  • 373
  • 1196
  • 568
  • 28
  • 44
  • 2
  • 1128
  • 1197
  • 5

Found 1202 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

EC17 for Intraoperative Imaging in Occult Ovarian Cancer

18 years or above
All genders
Phase 1
Interventional
The overall prevalence of Ovarian Cancer in the United States according to the US SEER Registry is 182,710 women. Ovarian cancer also has the highest mortality rate of the gynecological cancers. The overall five-year survival rate is 45% and for Stages III and IV it is only 20-25%. The majority …
Learn More

CART-38 in Adult AML and MM Patients - 1

99 years or below
All genders
TX Study See protocol section 2 See protocol section 2 See protocol section 4
Learn More

CART-38 in Adult AML and MM Patients - 1

99 years or below
All genders
TX Study See protocol section 2 See protocol section 2 See protocol section 4
Learn More

CART-38 in Adult AML and MM Patients - 1

99 years or below
All genders
TX Study See protocol section 2 See protocol section 2 See protocol section 4
Learn More

CART-38 in Adult AML and MM Patients - 1

99 years or below
All genders
TX Study See protocol section 2 See protocol section 2 See protocol section 4
Learn More

NCT Update study

99 years or below
All genders
TX Study See protocol section 2 See protocol section 2 See protocol section 4
Learn More

NCT Update study-4

99 years or below
All genders
TX Study See protocol section 2 See protocol section 2 See protocol section 4
Learn More

A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia (SUGR)

18 years - 65 years
All genders
Phase 1/2
Interventional
This study will evaluate the safety, efficacy and durability of SR-02 administered to the omentum of patients of Type 1 diabetes with severe recurrent hypoglycemia. The study will also help establish the optimal treatment dose. Although this study is open to patients with all HLA or blood types, immunosuppression to …
Learn More

NCT Update study-4

99 years or below
All genders
TX Study See protocol section 2 See protocol section 2 See protocol section 4
Learn More

Test irb sync may 27 2025

99 years or below
All genders
verification email study 2
Learn More
1121 - 1130 of 1202